StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

Thioglycolic Acid → (R)-6-(3-isopropyl-1-methyl-1H-pyrazol-5-yl)-2-(3-methyl-1-tosyl-1H-indol-4-yl)-4-(3-methylpiperazin-1-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine

HRID 80810
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 80810
[CH:1]([C:4]1[CH:8]=[C:7]([N:9]2[CH2:57][CH2:56][C:12]3[N:13]=[C:14]([C:36]4[CH:44]=[CH:43][CH:42]=[C:41]5[C:37]=4[C:38]([CH3:55])=[CH:39][N:40]5[S:45]([C:48]4[CH:54]=[CH:53][C:51]([CH3:52])=[CH:50][CH:49]=4)(=[O:47])=[O:46])[N:15]=[C:16]([N:17]4[CH2:22][CH2:21][N:20](S(C5C=CC=CC=5[N+]([O-])=O)(=O)=O)[C@H:19]([CH3:35])[CH2:18]4)[C:11]=3[CH2:10]2)[N:6]([CH3:58])[N:5]=1)([CH3:3])[CH3:2].C1CCN2C(=NCCC2)CC1.SCC(O)=O>CN(C=O)C.O.ClCCl>[CH:1]([C:4]1[CH:8]=[C:7]([N:9]2[CH2:57][CH2:56][C:12]3[N:13]=[C:14]([C:36]4[CH:44]=[CH:43][CH:42]=[C:41]5[C:37]=4[C:38]([CH3:55])=[CH:39][N:40]5[S:45]([C:48]4[CH:49]=[CH:50][C:51]([CH3:52])=[CH:53][CH:54]=4)(=[O:46])=[O:47])[N:15]=[C:16]([N:17]4[CH2:22][CH2:21][NH:20][C@H:19]([CH3:35])[CH2:18]4)[C:11]=3[CH2:10]2)[N:6]([CH3:58])[N:5]=1)([CH3:2])[CH3:3]
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 3

HCID 1133Thioglycolic AcidHCID 811841,8-Diazabicyclo(5.4.0)undec-7-eneHCID 71240484HCID 71240484, Verbindung

Produkt 1

HCID 71240581(R)-6-(3-isopropyl-1-methyl-1H-pyrazol-5-yl)-2-(3-methyl-1-tosyl-1H-indol-4-yl)-4-(3-methylpiperazin-1-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine

Reagenzien, Katalysatoren, Lösungsmittel 3

HCID 962
Water
Lösungsmittel
HCID 6228DimethylformamideLösungsmittel
HCID 6344DichloromethaneLösungsmittel

Versuchsvorschrift

To a solution of (R)-6-(3-isopropyl-1-methyl-1H-pyrazol-5-yl)-2-(3-methyl-1-tosyl-1H-indol-4-yl)-4-(3-methyl-4-((2-nitrophenyl)sulfonyl)piperazin-1-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine (105 mg, 0.127 mmol) in DMF (3 mL) was added DBU (0.1 mL, 0.64 mmol) followed by 2-mercaptoacetic acid (0.018 mL, 0.255 mmol). The mixture was stirred for 3 hours and then diluted with water and dichloromethane. The layers were separated and the aqueous layer was extracted three additional times with dichloromethane. The organic layers were combined, dried over Na2SO4, filtered and concentrated. The resulting residue was purified via silica gel flash chromatography [4-25% (2 M NH3 in MeOH)/DCM] to provide (R)-6-(3-isopropyl-1-methyl-1H-pyrazol-5-yl)-2-(3-methyl-1-tosyl-1H-indol-4-yl)-4-(3-methylpiperazin-1-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine. MS (ESI+) m/z 639.4 (M+H)+.

Aufarbeitung

  1. customThe layers were separated
  2. extractionthe aqueous layer was extracted three additional times with dichloromethane
  3. dry with materialdried over Na2SO4
  4. filtrationfiltered
  5. concentrationconcentrated
  6. customThe resulting residue was purified via silica gel flash chromatography [4-25% (2 M NH3 in MeOH)/DCM]

Quellen und Nachweise

ORD-Eintrag
ord-df0755466f0540289aa0b3a87923e88c
Quelldatensatz
uspto-grants-2014_09
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08846656B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion